Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Janeway

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Cancer Discovery|April 4, 2013
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumorJ Keith Killian, Su Young Kim, Markku Miettinen, et al.
JAMA Oncology|October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical TrialNathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
JCO Precision Oncology|November 29, 2022
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood CancerLorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) NetworkAnne Lr Schuster, Norah L Crossnohere, Melinda Bachini, et al.
JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2025
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic RecommendationsDanielle K Manning, Guruprasad Ananda, Cheryl Eifert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Cancer Discovery|April 4, 2013
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumorJ Keith Killian, Su Young Kim, Markku Miettinen, et al.
JAMA Oncology|October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical TrialNathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
JCO Precision Oncology|November 29, 2022
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood CancerLorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) NetworkAnne Lr Schuster, Norah L Crossnohere, Melinda Bachini, et al.
JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2025
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic RecommendationsDanielle K Manning, Guruprasad Ananda, Cheryl Eifert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
Pageof 15